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The DNA damage response (DDR) is a complex but coordi-
nated collection of biochemical reactions that serve to ame-
liorate or mitigate the effects of endogenous and induced 
DNA damage (Ciccia and Elledge 2010; Rimm 2006). 
Many biological functions are represented in the DDR, 
including DNA repair, cell cycle checkpoints, replication 
fork stabilization, transcriptional regulation, metabolism, 
and apoptosis. The DDR is activated not only in cancer, 
but also in pre-neoplastic lesions (Bartkova et al. 2005; 
Gorgoulis et al. 2005). These findings suggest that DNA 
damage occurs even in the early stages of carcinogenesis 
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Summary
The DNA damage response (DDR) coordinates DNA repair with cell cycle checkpoints to ameliorate or mitigate 
the pathological effects of DNA damage. Automated quantitative analysis (AQUA) and Tissue Studio are commercial 
technologies that use digitized immunofluorescence microscopy images to quantify antigen expression in defined tissue 
compartments. Because DDR is commonly activated in cancer and may reflect genetic instability within the lesion, a method 
to quantify DDR in cancer offers potential diagnostic and/or prognostic value. In this study, both AQUA and Tissue Studio 
algorithms were used to quantify the DDR in radiation-damaged skin fibroblasts, melanoma cell lines, moles, and primary 
and metastatic melanomas. Digital image analysis results for three markers of DDR (γH2AX, P-ATM, P-Chk2) correlated 
with immunoblot data for irradiated fibroblasts, whereas only γH2AX and P-Chk2 correlated with immunoblot data in 
melanoma cell lines. Melanoma cell lines displayed substantial variation in γH2AX and P-Chk2 expression, and P-Chk2 
expression was significantly correlated with radioresistance. Moles, primary melanomas, and melanoma metastases in 
brain, lung and liver displayed substantial variation in γH2AX expression, similar to that observed in melanoma cell lines. 
Automated digital analysis of immunofluorescent images stained for DDR biomarkers may be useful for predicting tumor 
response to radiation and chemotherapy. (J Histochem Cytochem 62:185–196, 2014)
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and that activation of the DDR may serve as a marker of 
developing or incipient genetic instability. DDR signaling 
has also been shown to be involved in oncogene-induced 
senescence (OIS), which is an important barrier to neoplas-
tic progression (Halazonetis et al. 2008). Both DDR and 
OIS include induction of phospho-H2AX (γH2AX), a 
marker of DNA double-strand breaks and stalled DNA rep-
lication forks, as well as phosphorylation and activation of 
p53, ATM and Chk2 (Bartkova et al. 2006; Di Micco et al. 
2006). Because the expression of DDR biomarkers may 
change during progression of benign precursors to malig-
nancy (Gorgoulis et al. 2005; Gray-Schopfer et al. 2006; 
Michaloglou et al. 2005), it is important to determine the 
activation state of the DDR during different stages of malig-
nant transformation. For example, whereas normal human 
melanocytes displayed low levels of expression of γH2AX, 
melanoma cell lines displayed significantly increased levels 
of this marker (Warters et al. 2005). These and other obser-
vations recently reported in the literature (Negrini et al. 
2010) have generated considerable interest in the develop-
ment of robust DDR biomarkers.
Although genomics studies have proven useful in dis-
secting the molecular complexities of cancer by providing 
unprecedented molecular resolution, cancer is ultimately a 
protein-level disease characterized by dysregulated intra-
cellular signaling (Hanahan and Weinberg 2000; Liotta and 
Petricoin 2000; Weinstein 2002). Proteomics approaches, 
including 2-D electrophoresis/mass spectrometry and pro-
tein arrays, have been utilized to systematically profile sig-
naling pathways in cancer (Petricoin et al. 2005; Petricoin 
et al. 2002). Yet, like microarray-based genomics, pro-
teomics techniques require biomolecular analytes derived 
from tumor lysates. Thus, tumor morphology and the spa-
tial relationships among different constituent cell types 
within individual tumors are destroyed using these 
approaches. Tumors are molecularly heterogeneous, and it 
is widely thought that this heterogeneity ultimately leads to 
post-therapy disease recurrence and patient mortality.
IHC is an established method for molecular classification 
of human breast cancer and stratification of patients to endo-
crine or biological therapies (Kumaki et al. 2011; Tang et al. 
2008). Automated quantitative analysis (AQUA) (Histo Rx; 
Branford, CT) (Camp et al. 2002) and Tissue Studio 
(Definiens, Munich, Germany) are software programs 
designed for automated quantification of protein expression 
in histological sections. Both systems rely upon standard 
protocols for the detection of protein by immunofluores-
cence microscopy and new techniques in computer-assisted 
imaging technology to quantify protein expression in spe-
cific cells and sub-cellular compartments of interest. 
Furthermore, technical advances have made it possible to 
perform quantitative expression profiling in high-density tis-
sue blocks (tissue microarrays [TMA]) constructed from 
hundreds of donor tissue blocks. Compared with traditional 
manual, pathologist-based, semi-quantitative (categorical) 
scoring of IHC staining, these digital analysis programs 
have improved reproducibility and sensitivity. For example, 
AQUA generates a near-continuous metric of protein expres-
sion (McCabe et al. 2005), has a greater dynamic range 
(4 logs) compared with manual IHC scoring (0.5 log) (Rimm 
2006), and has been utilized for the discovery of novel tumor 
sub-classes (Berger et al. 2005; Camp et al. 2003) and clus-
tering of tumors based upon protein expression profiles 
(Dolled-Filhart et al. 2006). Alternatively, Definiens soft-
ware has the ability to analyze and export data for individual 
cells, which allows for distinguishing different cellular pop-
ulations to address tumor heterogeneity. In addition, it has 
been used recently to determine the relative levels of nuclear 
(Varela et al. 2011) and cytoplasmic (Herrmann et al. 2012) 
protein markers in defined cellular populations and to assess 
the morphometric stromal features that are linked to breast 
cancer survival (Beck et al. 2011).
In this report, automated digital image analysis technol-
ogy was used to quantify three biomarkers of the DDR in 
normal fibroblast and melanoma cell lines. The results 
show that in situ expression of DDR biomarkers in cell lines 
measured by both AQUA and Tissue Studio technologies 
correlate well with protein expression levels determined by 
immunoblot analyses and can be successfully applied to 
measure expression of DDR biomarkers in TMA. The 
results also reveal substantial variation in the expression of 
DDR biomarkers in melanoma cell lines and tumor sam-
ples. This variation may provide insight into both the bio-
logical defects in melanoma cells as well as provide 




Formalin-fixed paraffin-embedded human tissues (moles 
and primary and malignant melanomas) used in this study 
were obtained from the UNC Hospitals surgical pathol-
ogy archive under the guidelines of (and protocol 
approved by) the UNC Institutional Review Board 
04-0986 and 08-0242.
Cell Culture
The human fibroblast line NHF1-hTERT—a cell line 
derived from normal neonatal foreskin fibroblasts (Boyer 
et al. 1991) and immortalized by ectopic expression of the 
catalytic subunit of telomerase (Heffernan et al. 2002)—
was grown and treated with ionizing radiation (IR), as pre-
viously described (Heffernan et al. 2007). Melanocytes and 
melanoma cell lines were grown as previously described 
(Kaufmann et al. 2008; Sambade et al. 2011).
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Antibodies
Rabbit polyclonal antibodies against ATM, H2AX, 
phospho-thr68-Chk2 (P-Chk2), rabbit monoclonal anti-
γ-Tubulin, and mouse monoclonal anti-Chk2 were from 
Cell Signaling Technology (Danvers, MA). Rabbit 
monoclonal anti-phospho-ser198-ATM (P-ATM) was 
from Epitomics Inc. (Burlingame, CA) and mouse 
monoclonal anti-phospho-ser139-H2AX (γH2AX) from 
Millipore (Billerica, MA). Goat polyclonal anti-actin and 
anti-goat IgG were from Santa Cruz Biotechnology 
(Dallas, TX). Anti-rabbit and mouse IgGs were from 
Amersham Pharmacia Biotech (Piscataway, NJ). Rabbit 
polyclonal anti-phospho-ser15-p53 was from Abcam 
(Cambridge, MA). Polyclonal rabbit antibodies to cyto-
keratin (CK) and S100 were from DakoCytomation 
(Carpinteria, CA).
Immunoblots
Protein concentrations were determined using the Bio-
Rad D
C
 Protein Assay (Bio-Rad, Hercules, CA). Equal 
amounts of cell lysate were loaded onto polyacrylamide 
gels. Phospho-proteins were detected using rabbit mono-
clonal antibodies against P-ATM, P-Chk2 and mouse 
monoclonal γH2AX, as previously described (Kaufmann 
et al. 2008). Total protein was detected using rabbit poly-
clonal antibodies to ATM and H2AX and a mouse mono-
clonal antibody to Chk2. γ-Tubulin and actin were used 
as loading controls for melanoma cell lines. Proteins 
were detected with horseradish peroxidase-conjugated 
secondary antibodies using the Amersham ECL reagent 
(Amersham Pharmacia Biotech Inc.). Pixel intensities of 
target bands were determined using Image J (NIH, 
Bethesda, MD).
Cell Line Block Preparation and Construction of 
Cell Line Arrays
All cell lines were confirmed to be free of mycoplasma con-
tamination using the GenProbeR kit (Gen-Probe Inc., San 
Diego, CA), according to the manufacturer’s protocol. Cell 
pellets were fixed in 10% buffered formalin for 16–24 hr, 
washed twice in 70% ethanol, clotted in 2% low-melting 
agarose (#BP-165-25, Fisher Scientific, Pittsburgh, PA), 
and processed and embedded in paraffin (#23-021-400, 
Fisher Scientific). Individual cell line blocks were sectioned 
and stained with hematoxylin and eosin (H&E) (Richard 
Allan Scientific, Kalamazoo, MI) to verify the quality of the 
prepared cell clots and guide Cell Line Array (CLA) con-
struction. Three 1-mm diameter cores were removed from 
each donor cell line block and randomly embedded into 
recipient CLA blocks.
Tissue Selection and Tissue Microarray (TMA) 
Construction
Formalin-fixed paraffin-embedded tissues of moles (n=20), 
primary melanomas (n=19) and metastatic melanomas to 
brain (n=11), lung (n=6), and liver (n=3) were obtained 
from the UNC-CH pathology archives. A pathologist (P.G.) 
reviewed H&E-stained sections of moles and primary mela-
noma to confirm the diagnosis and adequacy of the speci-
mens. H&E-stained slides of the selected metastatic 
melanoma cases were reviewed by a surgical pathologist 
(C.R.M.) and representative areas of tumor and adjacent 
normal tissues were circled for coring.
Two TMA blocks, containing triplicate cores (0.6 mm) 
of melanoma metastases or adjacent normal tissues, were 
constructed. Both contained triplicate 0.6-mm cores from 
one preparation of sham and ionizing radiation (IR)-treated 
NHF1-TERT cells to serve as internal calibrators for fluo-
rescent immunohistochemistry (IF) quantification.
Five micron thick whole tissue sections (WTS) of pri-
mary melanoma and moles and CLA and TMA block sec-
tions were placed on positively charged glass slides. 
H&E-stained slides of melanoma and normal TMA were 
histopathology examined by light microscopy. TMA sec-
tions adjacent to the reviewed H&E slides were used for IF.
Fluorescent Immunohistochemistry
Single IF stains of CLA and sequential dual stains of TMA 
and WTS slides were carried out using a Bond fully-auto-
mated slide staining system (Leica Microsystems, Norwell, 
MA). Slides were deparaffinized in Bond dewax solution 
(AR9222) and hydrated in Bond wash solution (AR9590). 
Antigen retrieval for all antibodies was performed for 30 
min at 100C in Bond epitope retrieval solution 1, pH 6.0 
(AR9961). For single IF (CLA), after incubation with pri-
mary antibody (8 hr for P-Chk2, γH2AX and 1 hr for 
P-ATM), sections were incubated with an appropriate sec-
ondary antibody using the Bond polymer refine detection 
system (DS9800), followed with tyramide Cy5 amplifica-
tion (PerkinElmer, Boston, MA). For sequential dual IF, 
TMA slides were first incubated with γH2AX followed by 
the Bond polymer (DS9800) and tyramide Cy5 amplifica-
tion (PerkinElmer), respectively. After completion of 
γH2AX staining, a second primary antibody (S100 or CK) 
was applied for 1 hr, followed by Alexa-555–labeled goat 
anti-rabbit secondary antibody (Invitrogen, Carlsbad, CA). 
To stain nuclei and preserve the fluorescent signals, 
ProLong Gold antifade reagent containing 4′,6-diamidino-
2-phenylindole (DAPI) was used (Molecular Probes, 
Eugene, OR) on CLA and TMA slides. Nuclei of WTS and 
accompanying control CLA slides were stained with 
Hoechst 33258 (Invitrogen) and slides were mounted with 
ProLong Gold antifade reagent (Molecular Probes).
188 Nikolaishvilli-Feinberg et al.
Staining Controls
In order to normalize for staining variability and to ensure 
that antibody staining/detection was not saturated, the same 
preparation of sham-treated and irradiated NHF1-TERT 
cells were incorporated into the (1) TMAs containing meta-
static melanomas and surrounding tissues, (2) the CLA con-
taining melanoma cell lines, and (3) the CLAs that were 
stained along with each batch of whole tissue sections of 
primary melanomas and moles. After antibody staining and 
digital imaging, TMA/CLA cores containing sham and irra-
diated fibroblasts were analyzed to ensure that a dose-
response was detected (signal from antibody staining 
remained in the linear detection range). Specific informa-
tion on how intensity data from fibroblast controls were 
used for data normalization is described further in the figure 
legends.
AQUA Analyses
H&E-stained CLA, TMA, and WTS sections were digitally 
imaged (20× objective) using the Aperio ScanScope XT 
(Aperio Technologies, Vista, CA). High-resolution acquisi-
tion (20× objective) of CLA and TMA IF slides in the 
DAPI, Cy3 and Cy5 channels was performed using a 
PM2000 (HistoRx, New Haven, CT) as described in detail 
(Camp et al. 2002). Images were analyzed using HistoRx 
AQUA software version 2.2. The AQUA algorithm was 
used to score expression of DDR biomarkers (target pro-
teins) labeled by Cy5 in DAPI-specific and S100- or 
CK-specific masks for cell lines and TMA, respectively. 
S100 was used to define melanoma metastases, while CK 
was used to define epithelial cells in adjacent normal lung 
and liver. Monochromatic and merged high-resolution 
(512×512 pixel, 1-µm resolution) images for each spot were 
generated. An illustration of AQUA methodology is shown 
in Fig. S1. All IF slides, including ones that were scanned in 
PM2000, were scanned in Aperio FL and images were 
archived in Aperio Spectrum. 
Tissue Studio Analyses
For biomarker analysis using Definiens Tissue Studio (ver 
3.0; Munich, Germany), slides were analyzed in the IF 
TMA Portal using the Nuclear Positive/Negative algorithm 
with minor alterations. An illustration of Tissue Studio 
nuclear segmentation can be found in Fig. S2.
Statistics
Microsoft Excel 2010 was used to calculate Pearson 
correlation coefficient R values. Linear regression was 
performed using GraphPad Prism 5 (La Jolla, CA). 
P-values less than or equal to 0.05 were considered statis-
tically significant.
Results
Expression of DDR Biomarkers in NHF1-hTERT 
Cells Treated with IR
Four DDR phospho-proteins were initially evaluated in cell 
lines and normal skin specimens: γH2AX, P-p53, P-ATM 
and P-Chk2. Diploid human fibroblasts were treated with 
IR to induce DNA double-strand breaks and then harvested 
30 min after irradiation when the responses to DNA damage 
were maximal (data not shown). Although the P-p53 anti-
body reliably detected induction of P-p53 by western immu-
noblotting in irradiated human fibroblasts and melanocytes 
(Kaufmann et al. 2003; Kaufmann et al. 2008), the antibody 
produced unacceptably high cytoplasmic background in 
skin keratinocytes (data not shown) and was, therefore, not 
studied further. The other three phospho-proteins were 
induced by DNA damage in human skin fibroblasts as 
determined by western immunoblot analysis. Figure 1A 
shows the dose-response curve for induction of phospho-
proteins over IR doses spanning from 0.06-1.5 Gray (Gy). 
The phosphorylated forms of all three proteins were 
detected at background levels in untreated fibroblasts and 
IR induced a dose-dependent increase in the phosphoryla-
tion of the target protein. After normalizing phospho-pro-
tein signal to the signal from each corresponding total 
protein band and setting the value of the sham-treated con-
trol to unity, treatment with 1.5 Gy IR increased the expres-
sion of the biomarkers by up to 147-fold over the 
sham-treated controls. In a separate experiment, immunob-
lots were performed using the entire nylon membrane to test 
for non-specific, cross-reacting bands. The γH2AX anti-
body detected no non-specific bands, whereas the P-Chk2 
and P-ATM antibodies detected cross-reacting bands (data 
not shown). AQUA analysis (described below) suggested 
that the P-ATM cross-reacting protein was nuclear and con-
tributed to background IF signals in fibroblast nuclei. The 
cross-reacting protein bands seen with P-Chk2 antibody did 
not appear to be nuclear and did not produce a substantial 
nuclear IF signal background. For each of the three DDR 
biomarkers, expression was stringently dependent upon the 
applied dose of IR (Fig. 1A).
Aliquots of the same cell preparations that were tested in 
Figure 1A were fixed in formalin, embedded in paraffin and 
processed for IF analysis of phospho-protein expression as 
described in the Materials & Methods. The DDR biomark-
ers were visualized by tyramide Cy5 amplification (red), 
and nuclei were stained with DAPI (blue). AQUA quanti-
fied the total level of red in the regions of the section that 
were stained blue with the DAPI (cell nuclei). All three bio-
markers displayed a linear increase in IF signal as the level 
of IR-induced DNA damage was increased (Fig. 1B). The 
P-Chk2 biomarker displayed the greatest dynamic range by 
AQUA with the expression signal in 1.5 Gy-treated cells 
being increased to nearly 10-times the background mea-
sured in the sham-treated controls. Photomicrographs show 
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the IR–dose-dependent increase in P-Chk2 IF signal in 
human fibroblast nuclei (Fig. 1D). The IR-induced signal of 
γH2AX after 1.5 Gy was 5-times that of the control, and the 
induced signal of P-ATM was less than twice that of the 
control background. The high background for the IF signal 
seen with the P-ATM marker likely reflects the presence of 
the cross-reacting protein that was detected by immunoblot 
analysis.
The Cy5 fluorescence intensities over fibroblast nuclei 
(AQUA IF scores) were highly correlated with the expres-
sion of DDR phospho-proteins as measured by western 
immunoblots (Fig. 1C). The correlations between western 
immunoblot detection of phospho-protein and AQUA 
quantification were high (P-ATM, R2=0.89, P=0.005; 
P-Chk2, R2 =0.99, P≤0.0001; γH2AX, R2=0.97, P=0.0003).
To demonstrate that the correlation between IF-determined 
levels and western blot data for DDR proteins was indepen-
dent of the analysis methodology, we used Tissue Studio to 
determine P-Chk2 and γH2AX levels. Using IF-stained digi-
tal images from a CLA containing sham-treated and irradi-
ated NHF1 cells, which were not collected at the same time 
as cells used for the western blot analysis described above, 
we found a linear dose-response to IR and a high correlation 
between Tissue Studio IF-determined levels of P-Chk2 and 
γH2AX and western blot data (R2=0.97, P=0.0151 and 
R2=0.99, P=0.0069, respectively; Fig. S3). These data indi-
cate that the IF quantification of P-Chk2 and γH2AX is 
reproducible across digital analysis programs and platforms 
and CLA preparations.
Expression of DDR Biomarkers in Melanoma 
Cell Lines
To assess DDR biomarker quantification further, nine 
human melanoma cell lines were compared for biomarker 
Figure 1. Correlation between western immunoblot and IF 
scores for DNA damage response (DDR) biomarker expression. 
(A) Cells from the diploid human skin fibroblast line, NHF1-
hTERT, were harvested for western immunoblot analysis of 
protein expression 30 min after sham treatment or treatment 
with various doses of IR. Phospho-proteins were detected using 
antibodies against P-ATM, P-Chk2 and γH2AX. Total biomarker 
protein was detected using antibodies against ATM, Chk2 and 
H2AX. Pixel intensities in protein bands were determined using 
Image J. Values in IR-treated samples (beneath each set of blots) 
are expressed relative to the sham-treated control. (B) Aliquots 
of cell lines isolated at the same time as those used for the 
western blots were used for cell line array (CLA) construction, 
as described in the Materials & Methods. The CLA sections 
were stained with the same primary phospho-antibodies used 
for immunoblot analysis. Target proteins were visualized with 
tyramide Cy5 amplification. The stained slides were scanned 
at 20× magnification in PM2000 (HistoRx) and digitized images 
were analyzed to determine Cy5 pixel intensities over DAPI-
stained nuclei. Panels show mean fluorescence signals from the 
three cores for each sample. Variation among the three cores 
was minimal (<10%). (C) Scatterplots show the correlations 
between AQUA intensity score and western immunoblot signals 
for the sham-treated and irradiated cell preparations with linear 
regression lines. (D) Photomicrographs showing IR–dose-
dependent expression of P-Chk2 in fibroblast nuclei. High-
resolution (512×512 pixel, 1-μm resolution; Bar = 50 µm) images 
were obtained using HistoRx AQUA version 2.2.
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expression by western immunoblot and AQUA. After har-
vesting cells, the preparations were split in two, with half 
being processed for immunoblot analysis and half being 
used to construct a small CLA for IF. Because the levels of 
ATM, Chk2 and H2AX varied across the melanoma cell 
lines, phospho-protein expression was normalized using 
γ-Tubulin or actin as loading controls (Fig. 2A). The mela-
noma cell lines displayed substantial variation in biomarker 
expression as determined by immunoblot analysis. A posi-
tive control of IR-treated fibroblasts was included in the 
immunoblot and AQUA analyses so that biomarker expres-
sion in the melanoma cell lines could be expressed relative 
to a reference. AQUA and immunoblot quantifications of 
biomarker expression were correlated for the P-Chk2 and 
γH2AX markers (Fig. 2B: R2=0.47 with P=0.04 for P-Chk2, 
R2=0.51 with P=0.03 for γH2AX), but not correlated for the 
P-ATM marker (R2=0.04 with P=0.6). This may be because 
of a large background signal for the IF due to cross-reacting 
proteins. The high molecular weight cross-reacting species 
seen in the fibroblasts was not present in the melanoma cell 
lines, but additional lower molecular weight cross-reacting 
species were present in the melanoma cell lines (data not 
shown). Photomicrographs document the great variation in 
P-Chk2 expression in melanoma cell lines (Fig. 2C).
Having demonstrated that AQUA-determined levels of 
the P-Chk2 and γH2AX biomarkers correlated well with 
western immunoblot data, a larger CLA, containing cell pel-
lets of 40 melanoma cell lines and one normal human mela-
nocyte culture (Sambade et al. 2011), was analyzed using 
these markers. Sham- or IR-treated normal human fibroblasts 
(NHF1-hTERT) were included in the CLA as controls. 
Figure 3A (P-Chk2) and Figure 4 (γH2AX) show that the 
normal melanocyte culture displayed low levels of P-Chk2 
and γH2AX biomarker expression, which were similar to the 
value scored for the sham-treated control fibroblasts. Two 
other melanocyte cultures were examined by immunoblot 
and shown to express low levels of γH2AX similar to those 
levels seen in NHF1-hTERT (data not shown). In contrast, 
the 40 melanoma cell lines displayed a range in the expres-
sion of P-Chk2 and γH2AX, varying from the low level seen 
in normal melanocytes to a level of expression equivalent to 
or higher than that measured in fibroblasts after 1.5 Gy. For 
γH2AX, 78% (31/40) of melanoma cell lines displayed 
AQUA scores that exceeded the level expressed in 1.5 Gy-IR 
fibroblasts; this represents a dose of radiation well within the 
range of the clinical doses used to treat patients (Fig. 4). 
Figure 2. Correlation between immunoblot and AQUA 
quantification of DNA damage response (DDR) biomarkers in 
melanoma cell lines. (A) Western immunoblot. Nine melanoma 
cell lines were harvested when in logarithmic growth and 
processed for western immunoblot and AQUA analyses of DDR 
phospho-protein expression. The NHF1-hTERT line that was 
sham-treated or exposed to 1.5 Gy 30 min before cell harvest 
served as negative and positive controls, respectively, for 
biomarker expression. Equal amounts of cell protein lysate were 
loaded onto polyacrylamide gels. γ-Tubulin and Actin were used 
as internal controls for protein loading. The pixel intensities of 
phospho-protein bands were determined and expressed relative 
to the positive control fibroblasts that were treated with 1.5 Gy, 
with normalization to the loading control. (B) AQUA correlation 
with immunoblot. Companion aliquots of melanoma cell line 
pellets used for the western immunoblots in (A) were fixed in 
formalin to prepare cell line blocks for cell line array (CLA). After 
IF and AQUA processing, the mean fluorescence intensities of 
each biomarker for melanoma nuclei were expressed relative to 
the NHF1-hTERT fibroblasts that were treated with 1.5 Gy 30 min 
before harvest and included in the CLA. Scatter plots show the 
correlations between relative biomarker expression by 
immunoblot and AQUA. (C) Photomicrographs showing variable 
expression of P-Chk2 in melanoma cell lines. High resolution 
(512×512 pixel, 1-µm resolution; Bar = 50 µm) images were 
obtained using HistoRx AQUA version 2.2.
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Similarly, 43% (17/40) of melanoma cell lines displayed lev-
els of P-Chk2 that exceeded the value of this marker in fibro-
blasts treated with 0.5 Gy of IR (Fig. 3A). We also analyzed 
IF images for this CLA using Tissue Studio, and found a high 
correlation between AQUA IF and Tissue Studio scores for 
both P-Chk2 (R2=0.86, P<0.0001; Fig. 3B) and γH2AX 
(R2=0.68, P<0.0001; Fig. S4A).
Given the great variation in AQUA scores among mela-
noma cell lines, it was of interest to determine whether the 
biomarkers were correlated with some biological property 
of the lines. Radiosensitivity was previously assessed for 
these cell lines as a continuous variable quantified as the D
0
 
from killing curves in radiation dose-response studies 
(Sambade et al. 2011). The AQUA P-Chk2 level in 
melanoma cell lines was found to be positively correlated 
with their radioresistance (Fig. 3C, R=0.42, P=0.01). A 
comparison of Tissue Studio IF scores with D
0
 scores for 
radiosensitivity also showed a significant correlation 
(R=0.36, P=0.04; data not shown). Although the expression 
of P-Chk2 was also correlated with the expression of 
γH2AX (R = 0.41), the expression of γH2AX was not well 
correlated with radiosensitivity (R=0.21, P=0.2367) in this 
experimental series. These results demonstrate that not only 
can DDR biomarker expression be quantified by automated 
digital image analysis in melanoma cell lines, but the levels 
of biomarker expression might provide an index of biologi-
cal function. In the case of P-Chk2, biomarker expression 
correlated with radiosensitivity.
Figure 3. IF quantification of P-Chk2 in melanoma cell lines. (A) AQUA quantification of P-Chk2 expression. One normal human 
melanocyte culture (NHM11) and 40 melanoma cell lines were harvested when in logarithmic growth, fixed in formalin and embedded in 
paraffin for construction of a cell line array (CLA). NHF1-hTERT fibroblasts that were sham-treated or exposed to various doses of IR 
30 min before harvest were included in the CLA as negative and positive controls, respectively, and for data normalization. Results were 
normalized to the 1.5 Gy equivalent for fibroblasts and show mean + SEM. (B) Correlation of IF analysis data from AQUA and Tissue 
Studio. Images from IF labeling of the melanoma CLA were scanned using Aperio FL and nuclei were analyzed for the expression levels 
of P-Chk2. All data were normalized to NHF1 sham-treated samples from the same CLA. (C) P-Chk2 DNA damage response (DDR) 
biomarker expression in melanoma cell lines is correlated with radiosensitivity. Melanoma cell lines were assayed for radiation-induced 
inactivation of colony formation and D
0
, as a measure of radiosensitivity, was calculated as previously described (Sambade et al. 2011). 
D
0
 data were statistically compared to AQUA-determined P-Chk2 levels.
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Expression of γH2AX in Moles, Primary 
Melanomas, Metastatic Melanomas and 
Surrounding Normal Tissues
A TMA of metastatic melanoma tissues was analyzed to 
assess the application of the AQUA technology to quantify 
the DDR in clinical specimens. A composite image of 
γH2AX in melanoma shows a high expression of γH2AX in 
nuclei within the S100 tumor mask (Fig. S1). As was seen 
in the melanoma cell lines, cells from the metastatic mela-
noma tumors displayed substantial variation in the expres-
sion of γH2AX. Four of the 20 specimens displayed an 
expression of γH2AX at a level exceeding that induced by 
1.5 Gy IR in fibroblasts, and 85% (17/20) of samples dis-
played AQUA γH2AX scores that exceeded that induced in 
fibroblasts with 0.5 Gy IR (Fig. 5A). Tissue Studio analysis 
of IF images from the same TMA was highly correlated 
with AQUA data (R2=0.88, P < 0.0001; Fig. S4B). Normal 
lung and liver tissue was collected from tumor blocks to 
score AQUA γH2AX in matched pairs of tumor and sur-
rounding normal tissue. In comparison with both the lung 
and liver normal tissue controls, the melanoma metastases 
displayed higher AQUA γH2AX signals (Fig. 5B). The 
expression of γH2AX in WTS of moles and primary mela-
nomas was also examined using AQUA. Similar to the 
results with melanoma cell lines and metastatic melanomas, 
both moles and primary melanomas displayed substantial 
variation in the expression of γH2AX (Fig. 5C), with moles 
showing higher average γH2AX AQUA scores relative to 
primary melanomas in this dataset (P=0.023).
Discussion
AQUA and Tissue Studio technologies provide efficient 
and accurate methods for the enumeration of protein expres-
sion in specific cellular and sub-cellular compartments. 
Previously, it was shown that AQUA scores and in situ pro-
tein concentrations were directly proportional (Cregger et al. 
2006; Harigopal et al. 2005; McCabe et al. 2005; Yu et al. 
2005a; Yu et al. 2005b). In this paper, we developed proto-
cols for assessing P-ATM, P-Chk2 and γH2AX biomarkers 
in a fully automated IHC staining system to standardize the 
process of automated digital analysis of IF images in a man-
ner applicable to both AQUA and Tissue Studio programs. 
Expression levels of these DDR biomarkers measured by 
AQUA and Tissue Studio in an IR dose-response experi-
ment were compared with protein levels measured by 
immunoblot analysis (Figs. 1 and S3). There was a very 
high correlation between biomarker quantification by 
immunoblot and IF data for cell line extracts and cell line 
blocks from normal human fibroblasts. The same high cor-
relation was obtained between the AQUA scores and 
immunoblot analysis in a kinetic experiment when the 
NHF1-hTERT cell line was collected at 0.5, 2, 6 and 24 hr 
after treatment with 1.5 Gy (data not shown). Thus, IF 
image analysis was as effective as immunoblotting for the 
detection of DDR biomarkers. After standardizing our 
assays for the digital IF quantification of DDR biomarkers 
on normal human fibroblast cells with induced DNA dam-
age, nine melanoma cells lines were analyzed, and, again, 
we found that IF-determined protein levels correlated well 
Figure 4. IF quantification of γH2AX in melanoma cell lines. NHF1-hTERT fibroblasts that were sham-treated or exposed to various 
doses of IR 30 min before harvest were included in the cell line array (CLA) as negative and positive controls, respectively, and for 
data normalization. AQUA quantification of the expression of γH2AX in the melanoma cell line CLA (see CLA description for Fig. 3A). 
Results were normalized to the 1.5 Gy equivalent for fibroblasts and the graph shows the mean + SEM.
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with immunoblotting (Fig. 2). Confident that our image-
based assays were accurately determining cellular protein 
levels for both P-Chk2 and γH2AX biomarkers, we 
expanded our analysis to a total of 40 melanoma cell lines 
and tissue sections from 22 metastatic melanoma cases. 
Because the P-ATM antibody had shown a non-specific 
nuclear signal, P-ATM was not used for this part of our 
analysis. The results for P-Chk2 and γH2AX, however, 
indicated that these two proteins may have different poten-
tial roles as clinical biomarkers.
Studies on γH2AX demonstrated that levels of this pro-
tein were highly variable in melanoma cell lines, with many 
having levels that were equivalent to, or higher than, that 
found in fibroblasts after 1.5 Gy of irradiation (Fig. 4). This 
variability agrees with data from Warters et al. (2005) who 
found a 17- to 42-fold increase in the number of γH2AX 
foci in nuclei from melanoma cells relative to normal 
melanocytes.
We also evaluated γH2AX in two TMAs to see if this 
variability could be detected in tissue sections. As men-
tioned above, one advantage that both AQUA and Tissue 
Studio have over traditional IHC is that the protein masks 
can be used to define sub-cellular regions of interest. This is 
especially useful for finding small regions of tumor in 
whole tissue sections and for protein markers that are 
expressed normally in some cellular compartments but 
aberrantly in tumors cells. For example, the intermediate 
filament protein vimentin is normally expressed in mesen-
chymal cells. However, in several non-mesenchymal tumor 
types, including melanoma, vimentin is over-expressed 
(Hendrix et al. 1992; Li et al. 2010). With digital IF analy-
sis, a cytokeratin mask can be used so that vimentin expres-
sion is only quantified in epithelial cells and not in the 
surrounding stroma, greatly increasing the accuracy of the 
analysis. To increase the accuracy of our study of γH2AX in 
melanoma tissue samples, the γH2AX antibody was used 
Figure 5. AQUA-determined protein levels of γH2AX in moles, primary melanomas, and melanoma metastases. (A) Tumor blocks 
were collected and two TMAs were assembled, one with cores from the melanoma metastases and one with cores from normal 
tissue surrounding the metastases. Insufficient normal brain tissue was available in paraffin blocks, so surrounding normal brain was not 
included in the TMA. Cores from fibroblasts treated with IR (as described for Fig. 1) were included in each TMA. For the melanoma 
TMA, S100 was used as the tumor mask. For the surrounding normal tissue TMA, pan-cytokeratin was used as the mask to select 
epithelial cells for analysis. AQUA scores for γH2AX were determined on the melanoma TMA for each core and normalized to the mean 
value of the unirradiated (sham-treated) normal fibroblast cores. Results show mean + SEM (n=2–3 cores). (B) AQUA γH2AX scores 
were determined for the melanoma and for the surrounding tissue TMA and each normalized to the mean value of the unirradiated 
normal fibroblast cores. Normalized AQUA γH2AX scores for the melanoma cases were divided by the AQUA γH2AX scores for the 
surrounding normal tissue. All melanoma metastases had AQUA γH2AX scores in excess of that scored in the normal surrounding 
tissue. (C) AQUA scores for γH2AX were determined on WTS from moles and primary melanomas using an S100 tumor mask. Higher 
γH2AX expression was evident in moles than in primary melanomas (P=0.023). Bars show mean ± SEM.
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with an anti-S100 antibody to stain the cytoplasm of mela-
nocytic lineage cells (Berger et al. 2004; Gould Rothberg et 
al. 2009). AQUA revealed substantial variations in γH2AX 
expression in metastatic melanoma similar to that seen for 
the melanoma cell lines, whereas the normal surrounding 
tissue had significantly lower γH2AX levels. These results 
agree well with previously published studies that used man-
ual evaluations (pathologist review) to analyze IHC results 
(Gorgoulis et al. 2005; Wasco et al. 2008). For example, 
Gorgoulis et al. (2005) reported that all of the dysplastic 
nevi and melanomas that were evaluated stained positive 
for γH2AX, whereas the surrounding normal skin did not. 
Additionally, with the aid of a sensitive assay, Wasco et al. 
(2008) found that γH2AX was expressed in melanomas 
with a higher positive index and a higher intensity as com-
pared with that in nevi, with metastatic melanomas having 
slightly higher staining intensity and numbers of positive 
cells than primary melanomas. Further evaluation of the 
data also found that γH2AX levels were not correlated with 
other diagnostic parameters, such as pathological stage 
(Wasco et al. 2008). The authors proposed that γH2AX lev-
els may not be suitable for an analysis of tumor progression 
or metastasis, but could be useful as a marker for tumori-
genesis in separating melanomas from nevi (Wasco et al. 
2008). It is possible, however, that IF analysis, with its 
greater dynamic range, may be more useful in discerning 
the stages of tumor progression based on γH2AX levels 
than the previously described manual scoring system 
(Gorgoulis et al. 2005).
Similar to our results for γH2AX, IF scores for P-Chk2 
in the melanoma cell lines displayed a wide range of expres-
sion levels and all but one cell line had levels higher than 
that observed in normal human melanocytes and fibroblasts. 
An increase in the number of P-Chk2–positive cells has 
been previously reported in dysplastic nevi and melanomas 
(Gorgoulis et al. 2005), but relative intensity levels of 
P-Chk2 were not determined.
We also compared our IF score results for P-Chk2 with 
other data previously collected for the melanoma cell lines 
used in the present study (Sambade et al. 2011). P-Chk2 
expression, which varied substantially among the mela-
noma cell lines (Fig. 3A), was significantly correlated with 
radiosensitivity (Fig. 3C). In contrast, we found an insig-
nificant correlation between radiosensitivity and γH2AX 
levels. Identifying predictors of radiation response for mel-
anoma is clinically important. Despite historical descrip-
tions of melanoma as categorically radioresistant (reviewed 
in (Stevens and McKay 2006)), our recent in vitro studies 
demonstrating that melanoma cells display a wide range of 
heterogeneity with respect to IR sensitivity (Sambade et al. 
2011), along with recent clinical observations demonstrat-
ing radiotherapeutic responses, support a larger role for 
radiotherapy in the management of melanoma (reviewed in 
(Khan et al. 2011)). Thus, the ability to predict 
radiotherapeutic response a priori—especially in a cancer 
such as melanoma, with a wide known range but unpredict-
able response to radiotherapy—would be of great value to 
radiation therapists. Thus, the levels of P-Chk2 have the 
potential for clinical utilization as a biomarker of the radio-
therapeutic response to treatment for melanoma and possi-
bly other cancers.
One caveat to using P-Chk2 as a biomarker is the poten-
tial instability of the phosphorylated target epitope. For 
example, in addition to γH2AX, we stained and analyzed 
the TMA containing melanoma and normal surrounding 
tissue samples for P-Chk2, but found that signal levels for 
this antibody on the tissue samples were much lower than 
those found for cell line samples (data not shown). 
Although all liver and most of the lung and brain samples 
showed some enrichment in P-Chk2 levels in tumor versus 
normal tissue, P-Chk2 IF scores for almost all tissue cores 
were below that of sham-treated NHF1 cells on the same 
TMA (staining levels were less than the reference). Because 
both cell lines and tissue samples on this TMA were paraf-
fin-embedded and subjected to antigen retrieval, differ-
ences in staining were likely due to handling of the tissue 
before the embedding process. For the cell lines used in 
this study, cell preparations were promptly fixed in 10% 
formalin after collection. Comparatively, with human tis-
sue samples, the time between collection and fixation is 
highly variable and the length of time at room temperature 
is one factor that can lead to the loss of phosphorylated 
epitopes. For example, Baker et al. (2005) found that 
allowing a tissue sample to stand at room temperature for 
30 min before fixation was enough time to lose nearly all 
phospho-Ser473-Akt signal in colon cancer xenografts. 
There is also evidence that the type of fixative used to pre-
serve the issue can influence tnhe phosphoprotein levels. 
Burns et al. (2009) found that Streck’s tissue fixative was 
better at preserving phosphoproteins in human samples 
than 10% formalin or 4% paraformaldehyde. It may be 
necessary, therefore, to adjust tissue collection and fixation 
protocols if phospho-proteins are to be clinically used as 
biomarkers.
In summary, as DDR biomarkers provide an index of 
the activation of the DDR system, they may correlate with 
DNA damage, genomic instability and a propensity for 
malignant progression and, therefore, be useful for cancer 
prognosis. Also, because radiation therapy and many che-
motherapies work by inducing DNA damage, DDR bio-
markers may be useful for predicting responses to 
therapeutic agents. Furthermore, when properly calibrated, 
the use of quantitative digital image analysis to evaluate 
levels of DDR proteins in tumor samples is at least as accu-
rate as classical manual methods of analysis, but has the 
advantage of being faster and more reproducible. Finally, 
our study has shown that both AQUA and Tissue Studio 
determination of levels of P-Chk2 and γH2AX expression 
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could be further developed into an assay as a guide to mel-
anoma diagnosis and as an aid to developing the therapeu-
tic plan.
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